Evidence map›Paper›PMID 34253879›Full record

ReviewBone marrow transplantation2021

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.

Thomas Luft, Peter Dreger, Aleksandar Radujkovic

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05502887 (The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms), which is not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05502887 recruitingnot on this mapstarted 2022, after this paper: background citation

The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms (EndoCDO-H). A Prospective Registry Study on Endothelial Functional Profile, Intervention Type and Clinical Outcome in Patients With Hematological Neoplasms

TypeobservationalSponsorProf. Dr. Thomas LuftRan2022 to 2032Enrolled1,000ConditionsHematological Neoplasm, Endothelial DysfunctionArmsSublingual in vivo microscopy with the Glycocheck microscope
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Percentage of CD56Annals of hematology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. EASIX as a predictor of 3-year mortality in aortic stenosis patients undergoing TAVR.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  17. Article
  18. Observational
  19. Article
  20. EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Thomas LuftDepartment Medicine V, University of Heidelberg, Heidelberg, Germany. thomas.luft@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-0387-1640
Peter DregerDepartment Medicine V, University of Heidelberg, Heidelberg, Germany. peter.dreger@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-7429-8570
Aleksandar RadujkovicDepartment Medicine V, University of Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8543-5016
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic stem cell transplantation (alloSCT) carries the promise of cure for many malignant and non-malignant diseases of the lympho-hematopoietic system. Although outcome has improved considerably since the pioneering Seattle achievements more than 5 decades ago, non-relapse mortality (NRM) remains a major burden of alloSCT. There is increasing evidence that endothelial dysfunction is involved in many of the life-threatening complications of alloSCT, such as sinusoidal obstruction syndrome/venoocclusive disease, transplant-associated thrombotic microangiopathy, and refractory acute graft-versus host disease. This review delineates the role of the endothelium in severe complications after alloSCT and describes the current status of search for biomarkers predicting endothelial complications, including markers of endothelial vulnerability and markers of endothelial injury. Finally, implications of our current understanding of transplant-associated endothelial pathology for prevention and management of complications after alloSCT are discussed.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationEndothelial CellsHumansRetrospective StudiesStem Cell TransplantationTransplantation ConditioningTransplantation, Homologous

Identifiers

PMID34253879
PMCPMC8273852
OpenAlexW3180036174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.